OMNIAMED Logo
COMPANY
Overview
CEO Message
Leadership
Partners
CI
Contact Us
R&D
R&D Overview
Pipeline Overview
Tech 1
Tech 2
Tech 3
PR
Press Release
Publications
Intellectual Property
RECRUIT
Careers
HOME
CONTACT US
ENG
ENG
KOR
COMPANY
Overview
CEO Message
Leadership
Partners
CI
Contact Us
R&D
R&D Overview
Pipeline Overview
Tech 1
Tech 2
Tech 3
PR
Press Release
Publications
Intellectual Property
RECRUIT
Careers
PR
OmniaMed Co., Ltd. opens up a new paradigm for
the development of treatments using Nitric Oxide functionality.
Press Release
Publications
Intellectual Property
Publications
2022.01.05
Lymph-Directed Self-Immolative Nitric Oxide Prodrug for Inhibition of ..
VIEW MORE
2020.04.21
Harnessing the Formation of Natural Killer–Tumor Cell Immunological Sy..
VIEW MORE
2020.02.24
Poly(cyclodextrin)-Polydrug Nanocomplexes as Synthetic Oncolytic Virus..
VIEW MORE
2019.11.14
A cyotosol-selective nitric oxide bomb as a new paradigm of an antican..
VIEW MORE
2019.10.26
Tannic acid-based nanogel as an efficient anti-inflammatory agent
VIEW MORE
2019.06.21
Tumor vasodilation by N-Heterocyclic carbene-based nitric oxide delive..
VIEW MORE
2019.05.13
Nitric Oxide-Scavenging Nanogel for Treating Rheumatoid Arthritis
VIEW MORE
2018.12.18
Hypoxia-Triggered Transforming Immunomodulator for Cancer Immunotherap..
VIEW MORE
2018.05.18
Programmed Nanoparticle-Loaded Nanoparticles for Deep Penetrating 3D C..
VIEW MORE
2017.12.27
Synthesis and Characterization of Nitric Oxide-Releasing Platinum(IV) ..
VIEW MORE
2017.12.15
DNA-Au Nanomachine Equipped with i-Motif and G-Quadruplex for Triple C..
VIEW MORE
2017.10.11
Therapeutic-Gas-Responsive Hydrogel
VIEW MORE
1
2
3